Glaxosmithkline Pharmaceuticals Ltd Financials Statements

Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

Consolidate
Standalone
Financial Year
Mar '25
Dec '24
Sep '24
Jun '24
Mar '24
Total Qtr Revenue cr
1,015.05
984.49
1,045.31
850.29
959.63
Other Income Qtr Cr40.6835.0734.5435.6429.83
Operating Revenues Qtr974.37949.421,010.77814.65929.80

*All values are in Cr.

Operating Expenses Qtr
641.18
657.50
689.06
584.11
672.54
Operating Profit Qtr
333.19
291.92
321.71
230.54
257.26
EBITDA Qtr Cr
373.87
326.99
360.94
266.18
289.49
Depreciation Qtr
14.72
18.80
16.86
16.41
18.10
Net Profit Qtr
262.87
229.88
252.50
182.33
194.48
Basic EPS Qtr
15.52
13.57
14.91
10.76
11.37
Open Demat Account
+91 -

Open Demat Account
+91 -